Last Saturday Brock Lesnar returned to the octagon for the first time in more than four years, as he beat Mark Hunt by unanimous decision at UFC 200 in Las Vegas. But less than a week after that dominant showing against Hunt, Lesnar was on the receiving end of some bad news from the United States Anti-Doping Agency.
According to a statement released by the Ultimate Fighting Championship, USADA alerted them to a possible violation regarding an out-of-competiton sample taken from Lesnar on June 28. Below is the full two-plus paragraph statement from the UFC.
“The UFC organization was notified today that the U.S. Anti-Doping Agency (USADA) has informed Brock Lesnar of a potential Anti-Doping Policy violation stemming from an out-of-competition sample collection on June 28, 2016. USADA received the testing results from the June 28, 2016 sample collection from the WADA-accredited UCLA Olympic Analytical Laboratory on the evening of July 14, 2016.
“USADA, the independent administrator of the UFC Anti-Doping Policy, will handle the results management and appropriate adjudication of this case. It is important to note that, under the UFC Anti-Doping Policy, there is a full fair legal review process that is afforded to all athletes before any sanctions are imposed. The Nevada State Athletic Commission also retains jurisdiction over this matter as the sample collection was performed in close proximity to Lesnar’s bout at UFC 200 in Las Vegas.
“Consistent with all previous potential anti-doping violations, additional information will be provided at the appropriate time as the process moves forward.”
Back in early June it was reported by Kevin Iole of Yahoo Sports that the four-month drug testing window usually required of retired athletes was waived for Lesnar, thus allowing him to be part of the fight card for UFC 200. The UFC requires athletes who have been retired to notify the organization in writing with four month’s notice, allowing for drug testing during the four-month period before they would be allowed to return to the octagon.
According to Iole’s report, the fact that drug testing policies had changed since Lesnar last fought in the UFC, a 2011 loss to Alistair Overeem at UFC 141, worked in Lesnar’s favor when it came to getting a waiver on the new rule.